GP-Act III Acquisition Corp. (GPAT) Financial Statements
Industry: Blank Checks
In fiscal 2025, GP-Act III Acquisition reported revenue of $0. Net income was $11.9M, or $0.33 per diluted share. Operating activities generated -$372,225 of cash. At fiscal year end, GP-Act III Acquisition held $309.4M in total assets against $14.7M in total liabilities.
Open the full interactive GP-Act III Acquisition financials → Quarterly statements, key ratios, valuation history and price charts.
GP-Act III Acquisition Key Stats
| Share Price | $11.03 |
|---|---|
| Market Cap | $251.9M |
| P/E Ratio | 33.4 |
| 52-Week Range | $10.60 – $11.16 |
| Shares Outstanding | 22.8 million (basic, 2026 Q2) |
GP-Act III Acquisition Income Statement
| FY 2024 | FY 2025 | |
|---|---|---|
| Revenue | $0 | $0 |
| Operating Income | -$564,973 | -$551,918 |
| Pre-Tax Income | $8.7M | $11.9M |
| Net Income | $8.7M | $11.9M |
| Diluted EPS | $0.34 | $0.33 |
GP-Act III Acquisition Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| Net Income | $3.1M | $2.9M | $2.2M | $290,121 |
| Diluted EPS | $0.09 | $0.10 | $0.06 | $0.01 |
GP-Act III Acquisition Balance Sheet
| FY 2024 | FY 2025 | |
|---|---|---|
| Current Assets | $675,355 | $188,111 |
| Total Assets | $297.5M | $309.4M |
| Current Liabilities | $631,605 | $634,612 |
| Total Long-Term Debt | $400,000 | — |
| Total Liabilities | $14.7M | $14.7M |
| Shareholders' Equity | -$13.9M | -$14.5M |
GP-Act III Acquisition Cash Flow Statement
| FY 2024 | FY 2025 | |
|---|---|---|
| Cash From Operations | -$584,718 | -$372,225 |
| Cash From Investing | -$287.5M | — |
| Cash From Financing | $288.6M | $1,313 |
Figures from GP-Act III Acquisition's 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full GP-Act III Acquisition financials page for every line item.
GP-Act III Acquisition Company Profile
| Ticker | GPAT |
|---|---|
| Exchange | Nasdaq |
| Industry | Blank Checks |
| Headquarters | New York, New York |
| Fiscal Year End | December 31 |
| SEC Filer Category | Non-accelerated filer, smaller reporting company, emerging growth company |
| SEC CIK | 0001834526 |
Frequently Asked Questions
What was GP-Act III Acquisition's revenue in fiscal 2025?
GP-Act III Acquisition (GPAT) reported revenue of $0 for fiscal 2025.
What was GP-Act III Acquisition's net income in fiscal 2025?
GP-Act III Acquisition reported net income of $11.9M for fiscal 2025.
What was GP-Act III Acquisition's earnings per share (EPS) in fiscal 2025?
GP-Act III Acquisition's diluted EPS was $0.33 for fiscal 2025 (adjusted for any later stock splits).
What was GP-Act III Acquisition's revenue last quarter?
In its most recent reported quarter (2026 Q2), GP-Act III Acquisition reported revenue of $0.
How many shares of GP-Act III Acquisition are outstanding?
GP-Act III Acquisition reported a weighted average of 22.8 million basic shares outstanding in 2026 Q2.
What is GP-Act III Acquisition's market cap?
Based on its latest closing price, GP-Act III Acquisition (GPAT) has a market capitalization of about $251.9M.
When does GP-Act III Acquisition's fiscal year end?
GP-Act III Acquisition's fiscal year end, as registered with the SEC, is December 31.
Where is GP-Act III Acquisition headquartered?
GP-Act III Acquisition lists its business address in New York, New York in its SEC filings.